Evaluación de proteínas de una isla de patogenicidad y de envolturas bacterianas de Escherichia coli 0157:H7 como vacunas para reducir su incidencia en bovinos

Enterohemorrhagic Escherichia coli (EHEC) is the pathogen responsible for the hemolytic uremic syndrome (HUS). Argentina has the world's highest incidence of HUS in children under five years. The serotype O157:H7 is the most prevalent in patients with HUS. Cattle are the primary reservoir of EH...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Vilte, Daniel Alejandro
Otros Autores: Mercado, Elsa Cristina
Formato: Tesis doctoral acceptedVersion
Lenguaje:Español
Publicado: Facultad de Farmacia y Bioquímica 2015
Materias:
Acceso en línea:http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=posgraafa&cl=CL1&d=HWA_1386
http://repositoriouba.sisbi.uba.ar/gsdl/collect/posgraafa/index/assoc/HWA_1386.dir/1386.PDF
Aporte de:
Descripción
Sumario:Enterohemorrhagic Escherichia coli (EHEC) is the pathogen responsible for the hemolytic uremic syndrome (HUS). Argentina has the world's highest incidence of HUS in children under five years. The serotype O157:H7 is the most prevalent in patients with HUS. Cattle are the primary reservoir of EHEC O157:H7, and the main source of infection for humans. Vaccination of cattle constitutes a pre-slaughter intervention strategy to reduce shedding of EHEC O157:H7. In this work, two vaccines were evaluated: the first comprises recognized colonization factors, Intimin and EspB proteins recombinantly produced; the second consisting of EHEC O157:H7 bacterial envelopes. An experimental inoculation model was developed, then a vaccination test for each vaccine with subsequent challenge was carried out. Our results indicate that systemic immunization with two doses of vaccine with recombinants EspB and Intimin could reduce the colonization and shedding of EHEC O157:H7. Colonization time and magnitude of excretion were also reduced by subcutaneous immunization of calves with O157: H7 bacterial envelopes. Additional trials would be needed to evaluate the efficacy of vaccines in calves under natural conditions.